LRCX
Lam Research Corporation
Updated 2026-04-01
Lam Research Corporation (LRCX) Stock Price, Analysis & Forecast 2026
$260.96 ▼ 1.58%
LRCX interactive stock chart
Key statistics
| Market cap | $266.81B | Today’s volume | 11,526,619 |
| Revenue (TTM) | $18.44B | Avg. daily volume | N/A |
| P/E ratio | 43.32x | Today’s range | 203.01 – 213.84 |
| Debt / equity | 0.44x | 52-week range | 56.32-256.68 |
| Net margin | 30.22% | Beta | 1.787x |
| ROE | N/A% | Current ratio | 2.26x |
| Dividend & yield | $1.01 (0.0%) | Next earnings | 2026-04-22 |
| FCF yield | 2.5% | FMP rating | B+ |
| DCF fair value | $50.62 (-76.3%) | Revenue growth | 23.7% |
See also: AMAT · ANET · ARM · INTC · INTU · All Semiconductors stocks
Is LRCX a good stock to buy in 2026?
Lam Research Corporation (LRCX) presents a mixed picture for investors in 2026. While its P/E ratio of 43.32x sits at a discount compared to the Semiconductor sector average of 46.8x, suggesting relative value within its industry, its Discounted Cash Flow (DCF) analysis points to a significant overvaluation at $50.62, representing a -76.3% deviation from the current price. However, analyst sentiment remains largely positive, with 76.0% rating LRCX stock a “Buy.” This analysis is not investment advice.
DCF Overvalued
Positive Analyst Consensus
2026 LRCX price scenarios
Based on analyst consensus of $275.76 from 50 analysts. Not a prediction by Alert Invest.
Requires:
- Robust global demand for advanced semiconductors drives increased capital expenditure from chipmakers.
- Lam Research successfully launches new, high-margin equipment for emerging technologies like AI and advanced packaging.
- Supply chain efficiencies further improve, leading to stronger-than-expected earnings beats.
Assumes:
- Steady growth in the semiconductor industry aligns with analyst expectations for forward revenue of $33.5B.
- LRCX maintains its competitive position, delivering on projected forward EPS of $8.73527.
- Minor macroeconomic headwinds are offset by sustained innovation and market share.
Key risks:
- A significant downturn in the global economy or a sharp drop in semiconductor demand.
- Increased competition or technological shifts erode Lam Research’s market share.
- Geopolitical tensions disrupt supply chains, impacting production and profitability.
How does LRCX compare?
Side-by-side valuation, growth, and analyst ratings vs top Technology competitors.
About Lam Research Corporation (LRCX)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. I
Lam Research Corporation, under the leadership of CEO Timothy Archer, is a pivotal player in the semiconductor equipment industry, employing approximately 18,600 dedicated individuals globally. The company’s distinctive strengths lie in its deep engineering expertise and its comprehensive portfolio of equipment solutions essential for manufacturing the world’s most advanced integrated circuits. LRCX stands out for its innovation in critical areas such as deposition, etch, and clean technologies, which are foundational processes in chip fabrication.
LRCX competitive moat and business analysis
Lam Research Corporation (LRCX) demonstrates a robust competitive advantage, underscored by its impressive net profit margin of 30.22%. This indicates strong pricing power and efficient cost management within the highly specialized semiconductor equipment sector. While specific Return on Equity (ROE) and Return on Invested Capital (ROIC) figures were not available for a direct comparison, the substantial net margin suggests that LRCX effectively converts revenue into profit, a key characteristic of a company with a durable economic moat. Their deep intellectual property and complex technological offerings create high barriers to entry for competitors.
For fiscal year 2025, Lam Research Corporation’s revenue streams are typically diversified across its various equipment and services offerings, crucial for front-end wafer fabrication. [Please note: specific segment and geographical revenue breakdowns are not available in the provided data for 2025-06-29, but generally, LRCX serves a global customer base primarily in Asia, with significant contributions from memory and foundry-logic segments.] This diversified exposure helps mitigate risks associated with reliance on a single product line or region, showcasing a well-balanced business model.
LRCX’s growth trajectory is strong, evidenced by a year-over-year revenue growth of 23.7%. This acceleration reflects sustained demand for semiconductor manufacturing tools, driven by advancements in artificial intelligence, 5G, and high-performance computing. The company’s consistent investment in R&D ensures it remains at the forefront of technological innovation, constantly enhancing its product portfolio to meet evolving customer needs. While no transcript quote was provided in the data, ongoing innovation is critical for maintaining this growth momentum and reinforcing its market position.
When evaluating LRCX stock, it’s insightful to compare its performance against key industry peers. In the dynamic semiconductor equipment space, LRCX vs AMAT (Applied Materials) provides a look at two dominant players with broad portfolios. Comparing LRCX vs ANET (Arista Networks) highlights different aspects of the technology sector, though ANET operates in networking. Finally, LRCX vs ARM (Arm Holdings) offers a contrast between equipment suppliers and intellectual property providers within the broader semiconductor ecosystem, each presenting unique investment propositions.
Lam Research Corporation analyst rating
Based on 50 analysts. 76.0% rate LRCX Buy or Strong Buy.
A “Buy” consensus from 76.0% of 50 analysts indicates a strong positive outlook for LRCX stock within the Technology sector. While “Strong Buy” typically suggests even higher conviction, a high percentage of “Buy” ratings is still a very favorable signal, particularly given the cyclical nature of the semiconductor industry.
LRCX financial scorecard
Comprehensive ranking of LRCX across four financial dimensions.
5.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| Debt / equity | 0.44x | Low debt |
| Current ratio | 2.26x | Healthy |
| FCF yield | 2.5% | Fair |
| DCF vs price | -76.3% | Overvalued |
| FMP debt score | 2/5 | Below avg |
10/10
| Metric | Value | Signal & strength |
|---|---|---|
| Gross margin | 49.8% | Good |
| Net margin | 30.22% | Excellent |
| EBITDA margin | 36.48% | Excellent |
| ROE | N/A | Low |
| ROA | N/A | Low |
| FMP ROE score | 5/5 | Above avg |
10/10
| Metric | Value | Signal & strength |
|---|---|---|
| Revenue growth YoY | +23.7% | Accelerating |
| Revenue (TTM) | $18.44B | Large scale |
| Forward EPS est. | $8.73527 | Analyst consensus |
| Forward revenue | $33.5B | Analyst consensus |
| FMP DCF score | 3/5 | Average |
3.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| P/E ratio | 43.32x | Fair |
| P/B ratio | 26.53x | Expensive |
| P/S ratio | 12.98x | Expensive |
| DCF fair value | $50.62 | Overvalued |
| FMP P/E score | 2/5 | Below avg |
| FMP overall | 3/5 | Average |
Is LRCX undervalued or overvalued?
The LRCX valuation shows a P/E ratio of 43.32x, which is currently trading at a slight discount compared to the Semiconductors sector average of 46.8x. This might suggest that LRCX stock could be relatively attractive within its immediate industry group, offering a marginally better price for its earnings compared to its peers.
However, a deeper look at the Discounted Cash Flow (DCF) analysis for LRCX stock reveals a fair value of $50.62, implying a significant -76.3% difference from its current trading price. This indicates that, based on future cash flow projections, the stock appears substantially overvalued. Investors considering LRCX valuation should reconcile these contrasting signals from industry P/E comparisons and intrinsic value models.
LRCX financial health & key metrics
| Metric | LRCX | Sector avg | Signal |
|---|---|---|---|
| P/E ratio | 43.32x | 46.8x | Fair value (discount to sector) |
| Net margin | 30.22% | — | Excellent |
| ROE / ROIC | N/A | — | N/A |
| Debt / equity | 0.44x | — | Low debt |
| FCF yield | 2.5% | — | Fair |
| Revenue growth | 23.7% | — | Strong growth |
| DCF fair value | $50.62 | — | Overvalued |
For value investors assessing LRCX stock, the financial health metrics offer a mixed but generally strong profile. While the DCF valuation suggests significant overvaluation at $50.62, other indicators paint a more favorable picture. The company boasts an excellent net margin of 30.22% and a healthy debt-to-equity ratio of 0.44x, signaling robust operational efficiency and sound financial management. Furthermore, strong revenue growth of 23.7% demonstrates the company’s ability to expand its top line effectively in a dynamic market. The P/E ratio, while high, is still at a discount to its sector average, providing some comparative relief, though the relatively low FCF yield of 2.5% points to a fair, rather than exceptional, cash flow generation relative to its market capitalization.
Lam Research Corporation earnings history & next report
Lam Research Corporation reported EPS of $1.27, beating estimates by 8.55%. Next earnings: 2026-04-22 with EPS estimate of $1.33.
Investors will be closely watching Lam Research Corporation’s upcoming earnings report on 2026-04-22, where the estimated EPS is $1.33. Key aspects to monitor include management’s commentary on semiconductor capital equipment spending trends, any updates on supply chain conditions, and guidance for future quarters. Given the previous beat by 8.55% with an EPS of $1.27, any deviation from this positive trajectory or conservative guidance could impact the short-term trajectory of LRCX stock.
LRCX daily short volume
Short volume data sourced from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated daily.
| Metric | Value | Context |
|---|---|---|
| Short volume ratio | 40.3% | 40-60% = moderate |
| Shares sold short | 1.51M | FINRA-reported for 2026-03-31 |
| Total reported volume | 3.74M | All FINRA ATS + OTC volume |
| Exempt short volume | 3.7K | Market-maker / arbitrage exempt trades |
| Signal | Moderate short activity | FINRA CNMS Consolidated |
Source: FINRA CNMS · Data for 2026-03-31 · Not investment advice · See all short volume data →
LRCX insider trading activity
Corporate insiders must report trades to the SEC within two business days.
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-10 | Talwalkar Abhijit Y | Director | Sale | 4,571 | N/A | $0 | SEC |
| 2026-03-06 | Rammohan Karthikeyan | Officer: Svp, Global Ops & Ent Solns | Sale | 0 | N/A | $0 | SEC |
| 2026-03-06 | Rammohan Karthikeyan | Officer: Svp, Global Ops & Ent Solns | Sale | 0 | N/A | $0 | SEC |
| 2026-03-06 | Rammohan Karthikeyan | Officer: Svp, Global Ops & Ent Solns | Sale | 0 | N/A | $0 | SEC |
| 2026-03-06 | Rammohan Karthikeyan | Officer: Svp, Global Ops & Ent Solns | Sale | 8,328 | N/A | $0 | SEC |
| 2026-03-04 | Bettinger Douglas R | Officer: Chief Financial Officer & Evp | Purchase | 26,480 | $98.15 | $2,599,091 | SEC |
Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice
Recent LRCX analyst rating changes
| Firm | Previous | New rating | Date | Action | |
|---|---|---|---|---|---|
| Barclays | Equal Weight | → | Equal Weight | 2026-03-10 | Reiterated |
| Morgan Stanley | Equal Weight | → | Equal Weight | 2026-02-25 | Reiterated |
| JP Morgan | Overweight | → | Overweight | 2026-01-29 | Reiterated |
| Stifel | Buy | → | Buy | 2026-01-29 | Reiterated |
| Goldman Sachs | Buy | → | Buy | 2026-01-29 | Reiterated |
Lam Research Corporation stock news today
No major news for Lam Research Corporation (LRCX) was reported this week.
How does LRCX compare to its peers?
For investors exploring alternatives or looking to diversify their portfolio within the Technology sector, understanding how LRCX stock compares to its key industry counterparts is essential. Lam Research operates in a specialized area of semiconductor manufacturing, but there are other significant players offering different exposures to the same underlying market growth.
AMAT (Applied Materials)
Applied Materials is a direct competitor to Lam Research, offering a broader range of equipment for semiconductor manufacturing. Investors often compare LRCX vs AMAT to assess market share, technological leadership, and valuation metrics in the core equipment segment.
ANET (Arista Networks)
While Arista Networks operates in data networking rather than direct semiconductor manufacturing equipment, it represents another high-growth technology stock that capitalizes on cloud and AI infrastructure. A comparison of LRCX vs ANET might appeal to investors looking for growth opportunities across different technology sub-sectors.
ARM (Arm Holdings)
Arm Holdings is a crucial intellectual property provider for semiconductor design, a different facet of the semiconductor industry altogether. Analyzing LRCX vs ARM could be useful for investors interested in the foundational technology behind chip design versus the equipment used to fabricate them.
Alert Invest · Free Newsletter
Get alerts when top investors buy a stock!
Track when institutional investors, insiders, and analysts change their positions. Alert Invest sends you a data-driven brief the moment it happens — free, every week.
- Institutional & insider moves
- Analyst upgrades & downgrades
- 100% free — unsubscribe anytime
FAQ — Lam Research Corporation (LRCX) stock
What is the market cap for LRCX?
As of 2026-04-01, LRCX market cap is $266.81B.
What is the P/E ratio for LRCX?
LRCX P/E is 43.32x vs Semiconductors sector avg 46.8x. While it trades at a slight discount to its sector, suggesting it’s comparatively less expensive within the semiconductor equipment industry, its absolute P/E value is still high.
What is the analyst price target for LRCX?
Consensus: $278.12 (29.1% upside). High: $325. Low: $200. 50 analysts as of 2026-04-01. Not a prediction by Alert Invest.
Is LRCX a good investment in 2026?
With 76.0% of analysts rating it a “Buy” and strong revenue growth of 23.7%, LRCX stock shows positive momentum. However, its P/E of 43.32x and a DCF fair value of $50.62 (indicating significant overvaluation) present a nuanced picture. Potential investors should weigh the strong analyst sentiment and growth against the current LRCX valuation. This is not investment advice.
Is LRCX overvalued or undervalued?
LRCX stock appears to be overvalued based on its Discounted Cash Flow (DCF) fair value of $50.62, which is significantly below its current trading price, representing a -76.3% difference. However, its P/E ratio of 43.32x is at a 3.5 discount to the Semiconductors sector average of 46.8x, suggesting it might be relatively less expensive compared to its industry peers.
For informational purposes only. Not investment advice. Data: Financial Modeling Prep & SEC EDGAR. Always do your own research.
